22 results
F-1/A
EVAX
Evaxion Biotech A/S
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
exceed our insurance coverage, our financial condition would be adversely affected. In the event of contamination or injury, we could be held liable … of our product candidates could result in patient injury or death. Any of these occurrences may materially harm our business, financial condition
F-1
EVAX
Evaxion Biotech A/S
12 Jan 24
Registration statement (foreign)
5:17pm
exceed our insurance coverage, our financial condition would be adversely affected. In the event of contamination or injury, we could be held liable … or managing the potential side effects of our product candidates could result in patient injury or death. Any of these occurrences may materially harm our
424B4
ssyl t55eckjju7b1kq2
5 Nov 21
Prospectus supplement with pricing info
4:47pm
F-1/A
zr9jnj
3 Nov 21
Registration statement (foreign) (amended)
7:50am
F-1
obqwe60p5gcifovbfv8
26 Oct 21
Registration statement (foreign)
7:02am
6-K
EX-99.2
698ab 8wk25
25 Oct 21
Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
6:00am
DRS
htyqe ic7qy780hqfz5x
25 Jun 21
Draft registration statement
12:00am
20-F
f324lhrjl25f647p
7 Apr 21
Annual report (foreign)
4:31pm
424B4
qzwy9t0mdu7w
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1/A
0rnry6 j0diwse
1 Feb 21
Registration statement (foreign) (amended)
4:56pm
F-1/A
59n7w
25 Jan 21
Registration statement (foreign) (amended)
7:01am
F-1/A
fuw vmmge1dvl
19 Jan 21
Registration statement (foreign) (amended)
5:05pm
F-1
iacaptmgic2 9t2t
8 Jan 21
Registration statement (foreign)
4:54pm
F-1
EX-10.1
suu1jh8c6rm7df9 xk1e
8 Jan 21
Registration statement (foreign)
4:54pm
DRS/A
inyh4 6xc
4 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
s2bto
4 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
p51wb
16 Dec 20
Draft registration statement (amended)
12:00am